Nov 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amgen, CrowdStrike and Micron Technology, on Wednesday.
HIGHLIGHTS
* Amgen Inc AMGN.O: HSBC raises target price to $381 from $343 |
* CrowdStrike CRWD.O: Jefferies raises target price to $600 from $515 |
* Micron Technology Inc MU.O: TD Cowen raises target price to $275 from $200 |
* Praxis Precision Medicines Inc PRAX.O: BTIG initiates coverage with buy rating |
* Universal Health Services Inc UHS.N: JP Morgan raises target price to $240 from $195 |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Aecom ACM.N: Citigroup raises target price to $152 from $150 |
* Aecom ACM.N: UBS cuts target price to $148 from $153 |
* Affirm Holdings Inc AFRM.O: Truist Securities cuts target price to $85 from $90 |
* Albemarle ALB.N: BMO raises target price to $136 from $125 |
* Amalgamated Financial AMAL.O: Piper Sandler raises target price to $28 from $27 |
* Amalgamated Financial AMAL.O: Piper Sandler raises to neutral from underweight |
* Amentum Holdings Inc AMTM.N: UBS initiates coverage with neutral rating and PT $25 |
* American Battery Technology Co ABAT.O: Alliance Global Partners ups PT to $7 from $6 |
* American Eagle Outfitters Inc AEO.N: UBS raises target price to $22 from $21.50 |
* Amgen Inc AMGN.O: HSBC raises target price to $381 from $343 |
* Anavex Life Sciences Corp. AVXL.O: H.C. Wainwright cuts target price to $20 from $42 |
* Arrowhead Pharmaceuticals ARWR.O: Leerink Partners raises PT to $44 from $23 |
* Arrowhead Pharmaceuticals ARWR.O: Piper Sandler raises target price to $70 from $45 |
* Arrowhead Pharmaceuticals ARWR.O: RBC raises target price to $52 from $45 |
* Artelo Biosciences Inc ARTL.O: Maxim Group cuts to hold from buy |
* Baidu Inc BIDU.O: Jefferies raises target price to $159 from $157 |
* Bank of America BAC.N: Oppenheimer cuts target price to $55 from $57 |
* Bellring Brands Inc BRBR.N: Bernstein cuts target price to $38 from $46 |
* Bellring Brands Inc BRBR.N: BofA Global Research cuts price objective to $28 from $50 |
* Bellring Brands Inc BRBR.N: BofA Global Research cuts to neutral from buy |
* Bellring Brands Inc BRBR.N: Deutsche Bank cuts target price to $35 from $38 |
* Bellring Brands Inc BRBR.N: Jefferies cuts target price to $48 from $52 |
* Bellring Brands Inc BRBR.N: JP Morgan cuts target price to $36 from $45 |
* Bellring Brands Inc BRBR.N: Morgan Stanley cuts target price to $41 from $43 |
* Bellring Brands Inc BRBR.N: Stifel cuts target price to $50 from $56 |
* Bill Holdings Inc BILL.N: Truist Securities cuts target price to $60 from $61 |
* Boston Omaha Corp BOC.N: TD Cowen cuts target price to $20 from $22 |
* Cartesian Therapeutics Inc RNAC.O: H.C. Wainwright cuts target price to $30 from $40 |
* Citigroup Inc C.N: Oppenheimer cuts target price to $120 from $123 |
* Coty Inc COTY.N: Berenberg cuts target price to $4.20 from $5.05 |
* CrowdStrike CRWD.O: Jefferies raises target price to $600 from $515 |
* Curbline Properties Corp. CURB.N: Citigroup raises target price to $27 from $25 |
* Curbline Properties Corp. CURB.N: Citigroup raises to buy from neutral |
* Dick's Sporting Goods Inc DKS.N: JP Morgan cuts target price to $228 from $235 |
* Dolby Laboratories Inc DLB.N: Rosenblatt Securities cuts target price to $85 from $95 |
* DoorDash DASH.O: Jefferies raises to buy from hold; raises PT to $260 from $220 |
* Dow Inc DOW.N: Citigroup cuts target price to $23 from $25 |
* Dynatrace Inc DT.N: Truist Securities cuts target price to $55 from $60 |
* Elanco Animal Health Inc ELAN.N: Argus Research raises to buy from hold |
* Eli Lilly LLY.N: Truist Securities raises target price to $1,182 from $1,038 |
* Energizer Holdings Inc ENR.N: Canaccord Genuity cuts target price to $20 from $29 |
* Energizer Holdings Inc ENR.N: JP Morgan cuts target price to $23 from $28 |
* Extreme Networks Inc EXTR.O: BofA Global Research initiates coverage with buy rating |
* Extreme Networks Inc EXTR.O: BofA Global Research initiates coverage with PT $24 |
* FIS FIS.N: Truist Securities cuts target price to $70 from $72 |
* Freeport-Mcmoran Inc FCX.N: BMO cuts target price to $47 from $48 |
* Freeport-Mcmoran Inc FCX.N: HSBC cuts target price to $48 from $50 |
* Freeport-Mcmoran Inc FCX.N: Raymond James cuts target price to $45 from $46 |
* Freeport-Mcmoran Inc FCX.N: Scotiabank cuts target price to $47 from $51 |
* Freeport-Mcmoran Inc FCX.N: Scotiabank raises to sector outperform from sector perform |
* Gitlab Inc GTLB.O: Truist Securities cuts target price to $44 from $55 |
* Gitlab Inc GTLB.O: Truist Securities cuts to hold from buy |
* Gladstone Capital Corp GLAD.O: B. Riley cuts target price to $22 from $27 |
* Gladstone Capital Corp GLAD.O: B. Riley raises to buy from neutral |
* Gladstone Capital Corp GLAD.O: Oppenheimer cuts target price to $22 from $26 |
* Gladstone Capital Corp GLAD.O: Oppenheimer raises to outperform from perform |
* GoHealth Inc GOCO.O: William Blair cuts to market perform rating |
* Helmerich and Payne Inc HP.N: Susquehanna raises target price to $31 from $26 |
* Highwoods Properties Inc HIW.N: Truist Securities cuts target price to $31 from $33 |
* Hilton Worldwide HLT.N: Bernstein cuts target price to $285 from $288 |
* Home Depot Inc HD.N: Bernstein cuts target price to $362 from $406 |
* Home Depot Inc HD.N: BofA Global Research cuts price objective to $430 from $450 |
* Home Depot Inc HD.N: D.A. Davidson cuts target price to $430 from $475 |
* Home Depot Inc HD.N: HSBC cuts target price to $400 from $445 |
* Home Depot Inc HD.N: Jefferies cuts target price to $438 from $474 |
* Home Depot Inc HD.N: JP Morgan cuts target price to $423 from $444 |
* Home Depot Inc HD.N: Mizuho cuts target price to $400 from $450 |
* Home Depot Inc HD.N: Morgan Stanley cuts target price to $395 from $430 |
* Home Depot Inc HD.N: RBC cuts target price to $376 from $401 |
* Home Depot Inc HD.N: Telsey Advisory Group cuts target price to $430 from $455 |
* Home Depot Inc HD.N: Truist Securities cuts target price to $379 from $421 |
* Home Depot Inc HD.N: UBS cuts target price to $445 from $475 |
* Horizon Technology Finance Corp HRZN.O: UBS raises target price to $6.50 from $6.25 |
* Hyatt Hotels Corp H.N: Bernstein raises target price to $188 from $177 |
* Incyte INCY.O: Jefferies raises target price to $120 from $102 |
* Insight Enterprises Inc NSIT.O: Canaccord Genuity initiates coverage with hold rating |
* Insight Enterprises Inc NSIT.O: Canaccord Genuity initiates coverage with PT $100 |
* Insulet Corp PODD.O: UBS raises target price to $400 from $355 |
* Insulet Corp PODD.O: UBS raises to buy from neutral |
* Interparfums Inc IPAR.O: Jefferies cuts target price to $100 from $115 |
* Intuitive Machines Inc LUNR.O: BofA Global Research raises PT to $9.50 from $8.50 |
* Ionis Pharmaceuticals Inc IONS.O: Leerink Partners raises target price to $85 from $83 |
* J M Smucker Co SJM.N: JP Morgan cuts target price to $122 from $126 |
* Jazz Pharmaceuticals Plc JAZZ.O: Truist Securities raises target price to $220 from $205 |
* Kinetik Holdings Inc KNTK.N: RBC cuts target price to $46 from $52 |
* LGI Homes Inc LGIH.O: JP Morgan cuts target price to $40 from $48.50 |
* LifeMD Inc LFMD.O: H.C. Wainwright cuts target price to $9 from $13 |
* Madrigal Pharmaceuticals Inc MDGL.O: Truist Securities raises PT to $640 from $580 |
* Marriott MAR.O: Bernstein raises target price to $329 from $327 |
* MBIA Inc MBI.N: KBW raises target price to $8.5 from $8 |
* Merck & Co Inc MRK.N: Berenberg raises target price to $95 from $90 |
* Micron Technology Inc MU.O: TD Cowen raises target price to $275 from $200 |
* Nuvalent Inc NUVL.O: JP Morgan raises target price to $147 from $125 |
* Nuvation Bio Inc NUVB.N: B. Riley initiates coverage with buy rating; target price $12 |
* Olema Pharmaceuticals Inc OLMA.O: JP Morgan raises target price to $55 from $32 |
* PagerDuty Inc PD.N: Truist Securities cuts target price to $20 from $23 |
* Palmer Square Capital BDC Inc PSBD.N: UBS cuts target price to $13 from $13.50 |
* Palvella Therapeutics Inc PVLA.O: Raymond James raises target price to $143 from $92 |
* Palvella Therapeutics Inc PVLA.O: Raymond James raises to strong buy from outperform |
* Parsons Corp PSN.N: UBS initiates coverage with buy rating and target price $107 |
* PNC Financial Services Group PNC.N: Oppenheimer cuts target price to $231 from $240 |
* Portland General Electric Co POR.N: Mizuho raises target price to $51 from $47 |
* Portland General Electric Co POR.N: UBS cuts to neutral from buy |
* Praxis Precision Medicines Inc PRAX.O: BTIG initiates coverage with buy rating |
* Praxis Precision Medicines Inc PRAX.O: BTIG initiates coverage with target price $424 |
* QuantumScape Corp QS.N: HSBC cuts to reduce from hold |
* QuantumScape Corp QS.N: HSBC raises target price to $10.50 from $5.30 |
* Rapport Therapeutics Inc RAPP.O: BTIG initiates coverage with buy rating |
* Rapport Therapeutics Inc RAPP.O: BTIG initiates coverage with target price $47 |
* Redwire Corp RDW.N: BofA Global Research cuts price objective to $6 from $9 |
* Relmada Therapeutics Inc RLMD.O: Mizuho raises target price to $10 from $1 |
* Relmada Therapeutics Inc RLMD.O: Mizuho raises to outperform from neutral |
* Rocket Lab Corp RKLB.O: BofA Global Research raises price objective to $60 from $50 |
* Runway Growth Finance Corp RWAY.O: UBS cuts target price to $12 from $12.50 |
* Semrush Holdings Inc SEMR.N: Keybanc cuts to sector weight from overweight |
* SentinelOne Inc S.N: Barclays cuts target price to $18 from $21 |
* Shift4 Payments Inc FOUR.N: Truist Securities cuts target price to $74 from $80 |
* Shore Bancshares Inc SHBI.O: Hovde Group initiates coverage with outperform rating |
* Shore Bancshares Inc SHBI.O: Hovde Group initiates coverage with price target $19 |
* Sionna Therapeutics Inc SION.O: BTIG initiates coverage with buy rating |
* Sionna Therapeutics Inc SION.O: BTIG initiates coverage with target price $50 |
* Tanger Inc SKT.N: Citigroup cuts to neutral from buy; cuts PT to $35 from $38 |
* Terns Pharmaceuticals Inc TERN.O: Truist Securities raises PT to $35 from $28 |
* TJX Companies Inc TJX.N: JP Morgan raises target price to $154 from $150 |
* Trevi Therapeutics Inc TRVI.O: Leerink Partners raises target price to $16 from $13 |
* Turning Point Brands Inc. TPB.N: Oppenheimer raises target price to $120 from $110 |
* U.S. Bancorp USB.N: Oppenheimer cuts target price to $64 from $66 |
* UGI Corp UGI.N: Jefferies raises target price to $45 from $44 |
* Ultragenyx Pharmaceutical Inc RARE.O: JP Morgan cuts target price to $120 from $125 |
* Universal Health Services Inc UHS.N: JP Morgan raises target price to $240 from $195 |
* Upwork Inc UPWK.O: Canaccord Genuity raises target price to $24 from $22 |
* Upwork Inc UPWK.O: UBS raises target price to $24 from $23 |
* Varex Imaging VREX.O: Oppenheimer cuts target price to $18 from $23 |
* Vaxcyte Inc PCVX.O: Leerink Partners raises target price to $77 from $60 |
* VTV Therapeutics Inc VTVT.O: BTIG initiates coverage with buy rating; target price $40 |
* Wesco International Inc WCC.N: RBC raises target price to $302 from $262 |
* Wesco International Inc WCC.N: RBC raises to outperform from sector perform |
* Westlake Corp WLK.N: Citigroup cuts target price to $75 from $88 |
* Zions Bancorporation NA ZION.O: Jefferies raises target price to $60 from $55 |
* Zions Bancorporation NA ZION.O: Jefferies raises to buy from hold |
* Zymeworks Inc ZYME.O: JP Morgan raises target price to $31 from $23 |
* Zymeworks Inc ZYME.O: Stifel raises target price to $40 from $30 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))